Gland Pharma Announces Schedule of Analyst and Institutional Investor Meetings
Gland Pharma Ltd has disclosed the schedule for upcoming meetings with various analysts and institutional investors. The company confirmed these events, which are scheduled to take place across June 2026, involving key financial research firms and investment groups.The detailed itinerary outlining the date, the associated investor or analyst firm, and the type of meeting is as follows:
| Date | Investor/Analyst/Fund Name | Type of Meeting |
|---|---|---|
| June 09, 2026 | Haitong Securities | One-on-One Meeting |
| June 09, 2026 | NDR arranged by ICICI Securities | One-on-One Meeting |
| June 10, 2026 | Midas Research | One-on-One Meeting |
| June 11, 2026 | Sohum Asset | One-on-One Meeting |
The company provided information regarding the schedule of these meetings. Gland Pharma also noted that the meeting schedules are subject to change due to exigencies arising on the part of the Investor, Analyst, or the Company.
GLAND Stock Price Movement
Shares of Gland Pharma Limited closed lower today, shedding 0.33% to settle at ₹2219.5. Trading activity for the day accounted for a total volume of 204,659 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.